Home › Funds › Two Sigma Investments › OCUL
Two Sigma Investments position in OCUL
OCULAR THERAPEUTIX INC · Health Care
Latest position (Q2 2026)1.22M sh
Reported value held$11.97M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 895.40K | $8.95M | New |
| Q4 2021 | 469.87K | $3.27M | Reduce |
| Q1 2022 | 483.28K | $2.39M | Add |
| Q3 2022 | 197.76K | $821.00K | New |
| Q4 2022 | 189.09K | $531.33K | Reduce |
| Q1 2023 | 323.42K | $1.70M | Add |
| Q2 2023 | 136.30K | $703.31K | Reduce |
| Q3 2023 | 116.10K | $364.55K | Reduce |
| Q4 2023 | 111.00K | $495.06K | Reduce |
| Q1 2024 | 19.41K | $176.66K | Reduce |
| Q2 2024 | 536.12K | $3.67M | Add |
| Q3 2024 | 207.42K | $1.80M | Reduce |
| Q4 2024 | 252.94K | $2.16M | Add |
| Q1 2025 | 461.23K | $3.38M | Add |
| Q1 2025 | 461.23K | $3.38M | Add |
| Q2 2025 | 110.83K | $1.03M | Reduce |
| Q2 2025 | 110.83K | $1.03M | Reduce |
| Q3 2025 | 234.21K | $2.74M | Add |
| Q4 2025 | 380.71K | $4.62M | Add |
| Q1 2026 | 1.83M | $15.50M | Add |
| Q2 2026 | 1.22M | $11.97M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding OCUL
- Fidelity Management & Research (FMR) 32.84M sh · $322.53M · Q2 2026
- BlackRock Inc 19.38M sh · $190.28M · Q2 2026
- Vanguard Group 11.58M sh · $140.52M · Q4 2025
- Geode Capital Management 5.02M sh · $49.32M · Q2 2026
- Point72 Asset Management 3.29M sh · $32.33M · Q2 2026
- Balyasny Asset Management 3.25M sh · $31.87M · Q2 2026
- Northern Trust Corp 1.80M sh · $17.67M · Q2 2026
- Goldman Sachs Group 1.76M sh · $17.30M · Q2 2026
- UBS Group AG 1.55M sh · $15.23M · Q2 2026
- Charles Schwab Investment Management 1.53M sh · $15.06M · Q2 2026
- Invesco Ltd 1.34M sh · $13.20M · Q2 2026